CYAD

Celyad Oncology (CYAD)

Celyad Oncology
Date:
Sort by:
 Showing the most relevant articles for your search:EU:CYAD
DateTimeSourceHeadlineSymbolCompany
09/20/20221:00AMGlobeNewswire Inc.Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction EU:CYADCelyad Oncology
08/05/20221:00AMGlobeNewswire Inc.Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights EU:CYADCelyad Oncology
08/01/20221:01AMGlobeNewswire Inc.Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial EU:CYADCelyad Oncology
07/28/20221:05AMGlobeNewswire Inc.Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call EU:CYADCelyad Oncology
06/24/20221:05AMGlobeNewswire Inc.Celyad Oncology Announces Leadership Updates EU:CYADCelyad Oncology
05/31/20222:00AMGlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) EU:CYADCelyad Oncology
05/17/20224:05PMGlobeNewswire Inc.Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference EU:CYADCelyad Oncology
05/05/20226:12PMGlobeNewswire Inc.CORRECTION - Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights EU:CYADCelyad Oncology
05/05/20224:05PMGlobeNewswire Inc.Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights EU:CYADCelyad Oncology
11/21/20174:30PMGlobeNewswire Inc.Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference EU:CYADCelyad Oncology
11/21/20174:30PMGlobeNewswire Inc.Celyad to Present at the 29th Annual Piper Jaffray Healthcare Conference EU:CYADCelyad Oncology
11/17/20171:00AMGlobeNewswire Inc.Celyad Announces Third Quarter 2017 Business Update EU:CYADCelyad Oncology
11/17/20171:00AMGlobeNewswire Inc.Celyad Announces Third Quarter 2017 Business Update EU:CYADCelyad Oncology
10/03/20179:06AMCercle FinanceCelyad: des premiers résultats prometteurs pour THINK. EU:CYADCelyad Oncology
10/03/20171:00AMGlobeNewswire Inc.Celyad reports a first complete response in a relapsed refractory AML patient in the THINK trial EU:CYADCelyad Oncology
10/03/20171:00AMGlobeNewswire Inc.Celyad reports a first complete response in a relapsed refractory AML patient in the THINK trial EU:CYADCelyad Oncology
09/20/20174:30PMGlobeNewswire Inc.Celyad to Present at the Cantor Fitzgerald Global Healthcare Conference EU:CYADCelyad Oncology
09/20/20174:30PMGlobeNewswire Inc.Celyad to Present at the Cantor Fitzgerald Global Healthcare Conference EU:CYADCelyad Oncology
08/29/20171:00AMGlobeNewswire Inc.Celyad Reports First Half 2017 Financial Results and Operational Progress EU:CYADCelyad Oncology
08/29/20171:00AMGlobeNewswire Inc.Celyad Reports First Half 2017 Financial Results and Operational Progress EU:CYADCelyad Oncology
08/04/20171:37AMCercle FinanceCelyad: révision de deux contrats. EU:CYADCelyad Oncology
08/04/20171:00AMGlobeNewswire Inc.Celyad announces new agreements with Celdara Medical and Dartmouth College EU:CYADCelyad Oncology
08/04/20171:00AMGlobeNewswire Inc.Celyad announces new agreements with Celdara Medical and Dartmouth College EU:CYADCelyad Oncology
07/20/20171:00AMGlobeNewswire Inc.Celyad announces initiation of the SHRINK trial EU:CYADCelyad Oncology
07/20/20171:00AMGlobeNewswire Inc.Celyad announces initiation of the SHRINK trial EU:CYADCelyad Oncology
06/21/20177:32AMCercle FinanceCelyad: publication sur NKR-2 dans 'Future Oncology'. EU:CYADCelyad Oncology
06/21/20175:00AMGlobeNewswire Inc.Celyad publishes additional pre-clinical data in support of THINK trial EU:CYADCelyad Oncology
06/19/20171:53AMCercle FinanceCelyad: résultats cliniques prometteurs. EU:CYADCelyad Oncology
05/30/20172:16AMCercle FinanceCelyad: délivrance d'un nouveau brevet américain. EU:CYADCelyad Oncology
05/30/20171:00AMGlobeNewswire Inc.Celyad obtains additional US patent for cancer treatment based on TCR-deficient allogeneic CAR-T cells EU:CYADCelyad Oncology
 Showing the most relevant articles for your search:EU:CYAD
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220928 19:25:53